Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about BDC, Lumira-Backed Biotherapeutics Company Files For IPO
Venture Capital

BDC, Lumira-Backed Biotherapeutics Company Files For IPO

by pehub.com posted 1year ago 331 views
Vancouver-based biotherapeutics company, Zymeworks Inc, has filed with Canadian and U.S. regulatory authorities for an initial public offering of its common shares. The IPO, which will give the company a listing on the New York Stock Exchange and the Toronto Stock Exchange under the ticker symbol "ZYME." Last year, Zymeworks closed one of Canada’s largest venture capital rounds, raising about $61.5 million. It was led by BDC Capital and Lumira Capital and joined by multiple other investors.